Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516100 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Mild Cognitive Impairment' returned 56 results - Page 1 of 3

  Sort by   
  Sorted by Rank Top-Bottom

Mild Cognitive Impairment Global Clinical Trials Review, Q1, 2011  
GlobalData, Jan 2011, Pages: 69
Mild Cognitive Impairment Global Clinical Trials Review, Q1, 2011 Mild Cognitive Impairment Global Clinical Trials Review, Q1, 2011 Summary Our clinical trial report, “Mild Cognitive Impairment


Mild Cognitive Impairment Global Clinical Trials Review, H1, 2012  
GlobalData, March 2012, Pages: 101
Mild Cognitive Impairment Global Clinical Trials Review, H1, 2012 Mild Cognitive Impairment Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Mild Cognitive


Mild Cognitive Impairment - Pipeline Review, Q4 2010  
Global Markets Direct, Dec 2010, Pages: 27
Mild Cognitive Impairment - Pipeline Review, Q4 2010 Mild Cognitive Impairment - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Mild Cognitive Impairment Pipeline Review, Q4 2010


Mild Cognitive Impairment - Pipeline Review, H2 2011  
Global Markets Direct, Aug 2011, Pages: 135
Mild Cognitive Impairment - Pipeline Review, H2 2011 Mild Cognitive Impairment - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Mild Cognitive Impairment - Pipeline Review, H2 2011


Mild Cognitive Impairment - Pipeline Review, H1 2012  
Global Markets Direct, April 2012, Pages: 120
Mild Cognitive Impairment - Pipeline Review, H1 2012 Mild Cognitive Impairment – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Mild Cognitive Impairment - Pipeline Review, H1 2012


Mild Cognitive Impairment - Pipeline Review, Q2 2011  
Global Markets Direct, April 2011, Pages: 167
Mild Cognitive Impairment - Pipeline Review, Q2 2011 Mild Cognitive Impairment - Pipeline Review, Q2 2011 Summary Global Markets Direct’s, 'Mild Cognitive Impairment - Pipeline Review, Q2 2011


Mild Cognitive Impairment and Early Alzheimer's Disease: Detection and Diagnosis  
John Wiley and Sons Ltd, April 2008, Pages: 160
Mild Cognitive Impairment and Early Alzheimer's Disease: Detection and Diagnosis Written by leading authorities in the field, this book describes the cognitive changes associated with age


Dementia: An Atlas of Investigation and Diagnosis  
Clinical Publishing, March 2007, Pages: 208
and mild cognitive impairment suggests that these conditions present in a variety of forms and progress at different rates, with a spectrum of disability ranging from a barely perceptible loss of mental


Alzheimer’s Disease – The Evaluation & Management of Dementia 2012  
Apollo Managed Care Consultants, Jan 2012, Pages: 70
Introduction and differential diagnosis Mild Cognitive Impairment (MCI) Contributing factors, potential Initial assessment Reversible causes of dementia Diagnostic criteria for dementia and Alzheimer


Alzheimer Disease - New Drugs, Markets and Companies  
Jain PharmaBiotech, May 2012, Pages: 534
on early detection at the stage of mild cognitive impairment and early institution of neuroprotective measures. The value of mental exercise in delaying the onset of Alzheimer's disease is being recognized


Long-Term Management of Dementia  
Informa Healthcare, Nov 2010, Pages: 264
at this debilitating disease. Scope of Dementia. Diagnosis of Mild Cognitive Impairment and Dementia Maria. Pharmacotherapy of Cognition. Management of Behaviors. Management of Function - Instrumental Activities


Epidemiology: Alzheimer's Disease - Differential aging between genders will dramatically impact prevalent cases  
Datamonitor, Jan 2012, Pages: 32
BIBLIOGRAPHY Journal articles Websites APPENDIX A Epidemiologic forecasting of mild cognitive impairment due to Alzheimer’s disease Sources of epidemiologic data Description of methods Results Current prevalent


Alzheimer's Disease Market Forecast  
Datamonitor, Nov 2011, Pages: 55
immunotherapies such as bapineuzumab, solanezumab, and Gammagard have the potential to grow the market by $7.6bn. Datamonitor forecasts that around 600,000 patients with mild cognitive impairment or mild


Advances in Alzheimer’s Disease Drug Discovery  
Business Insights, May 2011, Pages: 273
and mild cognitive impairment Prevalence and economic burden of AD Summary Introduction Prevalence Economic burden Potential impact of achieving delayed onset or slowed progression of AD Risk factors


FUNCTION AND BRAIN STRUCTURE IN AGING WITH COGNITIVE IMPAIRMENT. Edition No. 1  
VDM Publishing House, Feb 2010, Pages: 168
impairment and mild Alzheimer’s disease. Some of the factors explored herein are certain genetic polymorphisms, cognitive reserve proxies as well as the use of techniques able to transiently modify cortical


The Central Nervous Systems Market 2010 Report  
NeuroInsights, May 2010
Alzheimer's, addiction, ALS, anxiety, depressive disorders, epilepsy, migraine, mild cognitive impairment, Huntington's, multiple sclerosis, obesity, pain, Parkinson's, schizophrenia, age-related macular


Thought Leader Insight & Analysis Report: Alzheimer’s Disease Q2 2010  
Medpredict, May 2010, Pages: 143
are at risk of developing mild cognitive impairment and progressing on to Alzheimer’s disease, and treat them prophylactically. For patients with more advanced disease, new therapies are needed to slow


Type 1 Diabetes, Glucocorticoids and the Brain: a sweet connection. Edition No. 1  
VDM Publishing House, Dec 2009, Pages: 136
of the adrenal glands is the primary event leading to hypercorticism in diabetic mice. Furthermore, diabetic animals present hippocampal pathology suggesting mild neurodegeneration. Concurrently, cognitive


The Neurotechnology Industry 2011 Report  
NeuroInsights, May 2011, Pages: 500+
Alzheimer's, addiction, ALS, anxiety, depressive disorders, epilepsy, migraine, mild cognitive impairment, Huntington's, multiple sclerosis, obesity, pain, Parkinson's, schizophrenia, age-related macular


Product Profiles: Alzheimer's Disease - Immunotherapies can revolutionize treatment paradigm  
Datamonitor, Nov 2011, Pages: 150
and severities, from mild cognitive impairment to severe Alzheimer’s disease. However, Eisai faces a steep decline in revenues as generic donepezil take hold in the US, marketed competition heightens in Japan


Results:  First -   Prev -   1 -   2 -   3 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds